Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomas
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomas
Authors
Keywords
-
Journal
Neurosurgical Focus
Volume 38, Issue 3, Pages E2
Publisher
Journal of Neurosurgery Publishing Group (JNSPG)
Online
2015-03-02
DOI
10.3171/2015.1.focus14745
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular Pathways in Gliomagenesis and Their Relevance to Neuropathologic Diagnosis
- (2015) Christina L. Appin et al. ADVANCES IN ANATOMIC PATHOLOGY
- Targetable Signaling Pathway Mutations Are Associated with Malignant Phenotype in IDH-Mutant Gliomas
- (2014) H. Wakimoto et al. CLINICAL CANCER RESEARCH
- Diagnostic discrepancies in malignant astrocytoma due to limited small pathological tumor sample can be overcome by IDH1 testing
- (2014) Betty Y. S. Kim et al. JOURNAL OF NEURO-ONCOLOGY
- IDHMutation in Glioma
- (2014) Zorbey Turkalp et al. JAMA Neurology
- PDGFRAAmplification is Common in Pediatric and Adult High-Grade Astrocytomas and Identifies a Poor Prognostic Group in IDH1 Mutant Glioblastoma
- (2013) Joanna J. Phillips et al. BRAIN PATHOLOGY
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- IDH1 and IDH2 Mutations in Gliomas
- (2013) Adam L. Cohen et al. Current Neurology and Neuroscience Reports
- Prognostic significance of IDH mutation in adult low-grade gliomas: a meta-analysis
- (2013) Hairui Sun et al. JOURNAL OF NEURO-ONCOLOGY
- IDH/MGMT-driven molecular classification of low-grade glioma is a strong predictor for long-term survival
- (2013) S. Leu et al. NEURO-ONCOLOGY
- IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection
- (2013) Jason Beiko et al. NEURO-ONCOLOGY
- From genomics to the clinic: biological and translational insights of mutant IDH1/2 in glioma
- (2013) Gavin P. Dunn et al. Neurosurgical Focus
- Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma
- (2012) Dominik Sturm et al. CANCER CELL
- Comparison of a Strategy Favoring Early Surgical Resection vs a Strategy Favoring Watchful Waiting in Low-Grade Gliomas
- (2012) Asgeir S. Jakola et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Intrinsic Molecular Subtypes of Glioma Are Prognostic and Predict Benefit From Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Combination With Other Prognostic Factors in Anaplastic Oligodendroglial Brain Tumors: A Report From EORTC Study 26951
- (2012) Lale Erdem-Eraslan et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
- (2012) Gregory Cairncross et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951
- (2012) Martin J. van den Bent et al. JOURNAL OF CLINICAL ONCOLOGY
- 2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas
- (2012) Changho Choi et al. NATURE MEDICINE
- Magnetic Resonance of 2-Hydroxyglutarate in IDH1-Mutated Low-Grade Gliomas
- (2012) A. Elkhaled et al. Science Translational Medicine
- Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy
- (2011) Whitney B. Pope et al. JOURNAL OF NEURO-ONCOLOGY
- International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors
- (2011) A. B. Lassman et al. NEURO-ONCOLOGY
- Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
- (2010) Maria E. Figueroa et al. CANCER CELL
- DNA Methylation, Isocitrate Dehydrogenase Mutation, and Survival in Glioma
- (2010) Brock C. Christensen et al. JNCI-Journal of the National Cancer Institute
- Long-term outcome and survival of surgically treated supratentorial low-grade glioma in adult patients
- (2009) Rezvan Ahmadi et al. ACTA NEUROCHIRURGICA
- NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide
- (2009) Wolfgang Wick et al. JOURNAL OF CLINICAL ONCOLOGY
- Recurrence and malignant degeneration after resection of adult hemispheric low-grade gliomas
- (2009) Kaisorn L. Chaichana et al. JOURNAL OF NEUROSURGERY
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
- (2009) Lenny Dang et al. NATURE
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analysis of the IDH1 codon 132 mutation in brain tumors
- (2008) Jörg Balss et al. ACTA NEUROPATHOLOGICA
- Role of Extent of Resection in the Long-Term Outcome of Low-Grade Hemispheric Gliomas
- (2008) Justin S. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial
- (2008) Edward G. Shaw et al. JOURNAL OF NEUROSURGERY
- EXTENT OF SURGICAL RESECTION IS INDEPENDENTLY ASSOCIATED WITH SURVIVAL IN PATIENTS WITH HEMISPHERIC INFILTRATING LOW-GRADE GLIOMAS
- (2008) Matthew J. McGirt et al. NEUROSURGERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation